The skin gateway
to the Immune System

About us

Missing flash plugin. Please download the latest Adobe Flash Player:
Get Adobe Flash Player

Scientific Advisory Board

Professor Christophe Dupont
Details
Chairman of the Scientific Advisory Board, Professor Christophe Dupont is Head of the Pediatrics-Gastroenterology Department at the Necker Hospital in Paris. He is a member of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition and the Committee of Nutrition of the French Pediatric Society.
Professor Paul Henri Lambert
Details
Professor Paul Henri Lambert is the current Chairman for the Global Advisory Committee for Vaccine Safety (GACVS) at the World Health Organization (WHO). Between 2000 and 2004, Professor Lambert was Coordinator of the European Commission’s European project on the Improvement of Neonatal Vaccination and was the Chairman of the European Commission’s Steering Committee for Tubercular Bronchitis (TB) Vaccines Consortium (TBVAC) in 2004.
Professor Gideon Lack
Details
Professor Lack is head of the Pediatric Allergy department and Clinical Lead in Allergy at King’s College London as well as Head of the Children’s Allergy Service at Guy’s and St Thomas’ NHS Foundation Trust. His research is focused on the prevalence of food allergies in children and the relationship between food allergies, eczema, and asthma. He is currently working on novel immune-modulatory treatments for food allergies and on developing new strategies to prevent the development of allergies and asthma in children and adults. Professor Lack is a member of the British Medical Association (BMA), The European Academy of Allergology and Clinical Immunology (EAACI) and the Royal College of Pediatrics and Child Health.
Professor Philippe Eigenmann
Details
Professor Eigenmann is an Associate Professor at the Department of Infants and Adolescents at the Hôpital cantonal Universitaire Genève (HUG), Geneva, Switzerland, specializing in pediatric allergy diagnosis and treatment. His current research is focused on the pathogenesis of food allergy with regard to sensitization procedures in the bowel, as well as investigating therapeutic food allergy treatment strategies using mouse models.
Professor Zeiger
Details
Professor Zeiger, MD, PhD, is a Clinical Professor in the Department of Pediatrics at the UCSD School of Medicine in La Jolla, California, United States, and Adjunct Physician Investigator for Kaiser Permanente Southern California. In addition, Professor Zeiger serves on the Medical Advisory Boards for the Food Allergy and Anaphylaxis Network (FAAN) and the Food Allergy Initiative (FAI). Professor Zeiger’s current research activities focus on childhood asthma.
Professor Adkinson
Details
Professor Adkinson, MD, is a Professor of Medicine at Johns Hopkins Asthma and Allergy Centre. His research has contributed to modern day’s understanding of the mechanisms of allergen immunotherapy
Professor Spergel
Details
Professor Spergel, MD, is an Associate Professor of Pediatrics at the University of PennsylvaniaSchool of Medicine. He is also the Chief of the Allergy department and directs the Centre for Pediatric Eosinophilic Disorders at the Children’s Hospital of Philadelphia. He serves as an international expert on the treatment and diagnosis of food allergies.
Dr. Yamo Deniz
Details
Yamo Deniz, MD currently serves as the Global Head of Early and Late Clinical Development at GE Healthcare. Prior to joining GEHC in 2010, Dr. Deniz has held numerous senior clinical positions of increasing responsibilities in the Respiratory as well as Inflamation groups at Genentech and Roche, respectively. Dr. Deniz played a key role in the approval of Anti IgE (Xolair) for the treatment of Asthma in the US and EU and oversaw the lifecycle plan of the marketed product for other indications. In addition, he led Genentech’s Peanut Allergy program. After studying medicine at the University of Massachusetts, Dr. Deniz completed his subspecialty training in Pediatric Allergy & Immunology at Duke University Medical Center in North Carolina.

What is Epicutaneous Immunotherapy ?

Scientific Publications


Find out here DBV's latest contribution to scientific reviews

Legal Mention

CNIL number: 1544201 v 0

DBV technologies - siège social
Green Square - Bâtiment D
80/84 rue des Meuniers
92220 Bagneux
France
Phone: +33 (0)1 55 42 78 78
Fax: +33 (0)1 43 26 10 83

SIRET: 441772522 00013
RCS: Nanterre

Executive editor: Pierre-Henri Benhamou

Hosting service: OVH www.ovh.com

Design : l’enchanteur www.lenchanteur.com

Contact